Royalty Keeps Pushing $6.6B Buyout Despite Elan's Refusal
New York investment firm Royalty Pharma LLC on Wednesday reaffirmed its spurned $6.6 billion takeover offer for Irish life sciences firm Elan Corp., saying it had planned talks with several of...To view the full article, register now.
Already a subscriber? Click here to view full article